Kelly C. Goldsmith
- Neurology top 5%
- Neuroblastoma Research and Treatments 35
- Genetics top 10%
- Glioma Diagnosis and Treatment 4
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 8
- Oncology top 10%
- CAR-T cell therapy research 6
- Lung Cancer Research Studies 6
-
- Cell death mechanisms and regulation 12
- Cancer therapeutics and mechanisms 6
-
- Immune Cell Function and Interaction 3
- Co-authors
- Michael D. HogartyXueyuan LiuBrian LestiniAnnette VuMark FluchelBruce PawelTobey J. MacDonaldVictor Maximov
- Cited by
- NeurologyGeneticsCancer Research
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (9 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Kelly C. Goldsmith
46 papers receiving 907 citations
Peers
Comparison fields: 5 of 85
- Neurology 297
- Genetics 149
- Cancer Research 165
- Oncology 237
- Molecular Biology 543
Countries citing papers authored by Kelly C. Goldsmith
This map shows the geographic impact of Kelly C. Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly C. Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly C. Goldsmith more than expected).
Fields of papers citing papers by Kelly C. Goldsmith
This network shows the impact of papers produced by Kelly C. Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly C. Goldsmith. The network helps show where Kelly C. Goldsmith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kelly C. Goldsmith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 45 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 14 | |
| 12 | 2019 | 22 | |
| 13 | 2019 | 5 | |
| 14 | 2018 | 39 | |
| 15 | 2016 | 21 | |
| 16 | 2016 | 24 | |
| 17 | 2012 | 62 | |
| 18 | 2009 | 76 | |
| 19 | 2009 | 45 | |
| 20 | 2005 | 65 |
About Kelly C. Goldsmith
Kelly C. Goldsmith is a scholar working on Neurology, Oncology and Cancer Research, having authored 48 papers that have together received 911 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (35 papers), Cell death mechanisms and regulation (12 papers), Cancer, Hypoxia, and Metabolism (8 papers), CAR-T cell therapy research (6 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (6 papers), Glioma Diagnosis and Treatment (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Neurology (297 citations), Genetics (149 citations) and Cancer Research (165 citations). Kelly C. Goldsmith has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Michael D. Hogarty, Xueyuan Liu, Brian Lestini, Annette Vu, Mark Fluchel, Bruce Pawel, Tobey J. MacDonald, Victor Maximov, Srilatha Nalluri and C. Patrick Reynolds. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.